FDA Strengthens Hepatitis B Warning on 2 Cancer Drugs - Arzerra and Rituxan | Cancer - Advances, Knowledge, Integrative & Holistic Treatments | Scoop.it
WASHINGTON (Reuters) - U.S.health regulators have strengthened the warnings on two blood cancer drugs to reflect the risk that they may reactivate the hepatitis B virus in patients previously infected...